[
     {
          "id": "5c643485e842deac67000015",
          "body": "Are de novo mutations in regulatory elements responsible for neurodevelopmental disorders?",
          "type": "yesno",
          "documents": [
               "29551301",
               "29562236",
               "29544733",
               "29555651"
          ],
          "snippets": [
               {
                    "pmid": "29562236",
                    "text": "De novo mutations in regulatory elements in neurodevelopmental disorders.",
                    "chunk": 0
               },
               {
                    "pmid": "29562236",
                    "text": "The role of de novo mutations in regulatory elements affecting genes associated with developmental disorders, or other genes, has been essentially unexplored.",
                    "chunk": 2
               },
               {
                    "pmid": "29562236",
                    "text": "We identified de novo mutations in three classes of putative regulatory elements in almost 8,000 patients with developmental disorders.",
                    "chunk": 3
               },
               {
                    "pmid": "29562236",
                    "text": "Our findings represent a robust estimate of the contribution of de novo mutations in regulatory elements to this genetically heterogeneous set of disorders, and emphasize the importance of combining functional and evolutionary evidence to identify regulatory causes of genetic disorders.",
                    "chunk": 7
               },
               {
                    "pmid": "29562236",
                    "text": "Here we show that de novo mutations in highly evolutionarily conserved fetal brain-active elements are significantly and specifically enriched in neurodevelopmental disorders.",
                    "chunk": 4
               },
               {
                    "pmid": "29562236",
                    "text": "We estimate that, genome-wide, 1-3% of patients without a diagnostic coding variant carry pathogenic de novo mutations in fetal brain-active regulatory elements and that only 0.15% of all possible mutations within highly conserved fetal brain-active elements cause neurodevelopmental disorders with a dominant mechanism.",
                    "chunk": 6
               },
               {
                    "pmid": "29555651",
                    "text": "Mutations in key regulators of DNA methylation have shown that the balance between gene regulation and function is critical during neural development in early years of life.",
                    "chunk": 2
               },
               {
                    "pmid": "29562236",
                    "text": "We previously estimated that 42% of patients with severe developmental disorders carry pathogenic de novo mutations in coding sequences.",
                    "chunk": 1
               },
               {
                    "pmid": "29551301",
                    "text": "Dissecting the Functional Consequences of De Novo DNA Methylation Dynamics in Human Motor Neuron Differentiation and Physiology.",
                    "chunk": 0
               },
               {
                    "pmid": "29544733",
                    "text": "Given their essential developmental roles, it is not surprising that bHLH mutations and de-regulated expression are associated with various neurological diseases and cancers.",
                    "chunk": 6
               }
          ],
          "exact_answer": "Yes",
          "ideal_answer": "De novo mutations in highly evolutionarily conserved fetal brain-active elements are significantly and specifically enriched in neurodevelopmental disorders."
     },
     {
          "id": "5c6aef167c78d69471000023",
          "body": "Which tool has been developed for GPU-accelerated alignment of bisulfite-treated DNA sequences?",
          "type": "factoid",
          "documents": [
               "29524146",
               "29524143",
               "29524144",
               "29594810",
               "29579198",
               "29524145",
               "29554207"
          ],
          "snippets": [
               {
                    "pmid": "29554207",
                    "text": "Arioc: GPU-accelerated alignment of short bisulfite-treated reads.",
                    "chunk": 0
               },
               {
                    "pmid": "29579198",
                    "text": "Software tools for aligning methylation reads have not yet been comprehensively evaluated, especially for the widely used reduced representation bisulfite sequencing (RRBS) that involves enrichment for CpG islands (CGIs).",
                    "chunk": 3
               },
               {
                    "pmid": "29524145",
                    "text": "Here we describe the design of PCR primers that are used to amplify specific sequences from bisulfite-converted DNA, the preparation of sequencing libraries, the sequencing of these libraries on the MiSeq system, as well as the analysis of the sequence reads.",
                    "chunk": 3
               },
               {
                    "pmid": "29554207",
                    "text": "Motivation: The alignment of bisulfite-treated DNA sequences (BS-seq reads) to a large genome involves a significant computational burden beyond that required to align non-bisulfite-treated reads.",
                    "chunk": 1
               },
               {
                    "pmid": "29524146",
                    "text": "Here, we present a protocol for bisulfite DNA methylation analysis of targeted genomic regions using amplicon-based next-generation sequencing (NGS) on an Illumina sequencing system.",
                    "chunk": 4
               },
               {
                    "pmid": "29579198",
                    "text": "A comprehensive evaluation of alignment software for reduced representation bisulfite sequencing data.",
                    "chunk": 0
               },
               {
                    "pmid": "29524144",
                    "text": "Whole-genome bisulfite sequencing (WGBS) using next-generation sequencing technologies is currently considered as the gold standard for a comprehensive and quantitative analysis of DNA methylation throughout the genome.",
                    "chunk": 2
               },
               {
                    "pmid": "29594810",
                    "text": "We present a streamlined protocol for solid-phase extraction and bisulfite conversion of genomic DNA, which minimizes reagent use and simplifies the sample preparation protocol for implementation on a compact assay platform.",
                    "chunk": 5
               },
               {
                    "pmid": "29524143",
                    "text": "The use of whole genome bisulfite sequencing (WGBS) enables the genome-wide identification and quantification of DNA methylation patterns at single-base resolution and is the gold standard for analysis of DNA methylation.",
                    "chunk": 2
               },
               {
                    "pmid": "29524146",
                    "text": "DNA Methylation Analysis by Bisulfite Conversion Coupled to Double Multiplexed Amplicon-Based Next-Generation Sequencing (NGS).",
                    "chunk": 0
               }
          ],
          "exact_answer": "Arioc",
          "ideal_answer": "Arioc is a tool developed for GPU-accelerated alignment of bisulfite-treated DNA sequences."
     },
     {
          "id": "5c6b198f7c78d69471000025",
          "body": "Is there a deep-learning algorithm for protein solubility prediction?",
          "type": "yesno",
          "documents": [
               "29554211",
               "29562690",
               "29524250",
               "29584811",
               "29548976",
               "29554120"
          ],
          "snippets": [
               {
                    "pmid": "29554211",
                    "text": "In this work we propose, DeepSol, a novel Deep Learning-based protein solubility predictor.",
                    "chunk": 4
               },
               {
                    "pmid": "29554211",
                    "text": "Thus, it is imperative to develop novel, highly accurate in silico sequence-based protein solubility predictors.",
                    "chunk": 3
               },
               {
                    "pmid": "29554211",
                    "text": "DeepSol: a deep learning framework for sequence-based protein solubility prediction.",
                    "chunk": 0
               },
               {
                    "pmid": "29554211",
                    "text": "The superior prediction accuracy of DeepSol allows to screen for sequences with enhanced production capacity and can more reliably predict solubility of novel proteins.",
                    "chunk": 7
               },
               {
                    "pmid": "29554211",
                    "text": "Results: DeepSol outperformed all known sequence-based state-of-the-art solubility prediction methods and attained an accuracy of 0.77 and Matthew's correlation coefficient of 0.55.",
                    "chunk": 6
               },
               {
                    "pmid": "29562690",
                    "text": "Deep learning methods in conjunction with amino acid physicochemical property indices are then used for this purpose.",
                    "chunk": 6
               },
               {
                    "pmid": "29554120",
                    "text": "Predicting protein complexes using a supervised learning method combined with local structural information.",
                    "chunk": 0
               },
               {
                    "pmid": "29548976",
                    "text": "The vast majority of the predicted solubility values, using our developed models, fall within 2-fold of the experimentally determined values with high correlation coefficients.",
                    "chunk": 7
               },
               {
                    "pmid": "29584811",
                    "text": "Learned protein embeddings for machine learning.",
                    "chunk": 0
               },
               {
                    "pmid": "29524250",
                    "text": "We have used various types of description of the protein and different machine learning methodologies.",
                    "chunk": 3
               }
          ],
          "exact_answer": "Yes",
          "ideal_answer": "DeepSol, a deep learning framework, is designed for sequence-based protein solubility prediction."
     },
     {
          "id": "5c63286ae842deac6700000e",
          "body": "List clinical symptoms of the MECOM-associated syndrome",
          "type": "list",
          "documents": [
               "29545249",
               "29540340",
               "29528714",
               "29527032",
               "29560340",
               "29535429",
               "29525570",
               "29535059",
               "29557732",
               "29529530"
          ],
          "snippets": [
               {
                    "pmid": "29540340",
                    "text": "MECOM-associated syndrome: a heterogeneous inherited bone marrow failure syndrome with amegakaryocytic thrombocytopenia.",
                    "chunk": 0
               },
               {
                    "pmid": "29560340",
                    "text": "The characteristic signs of Hennekam syndrome are lymphangiectasia, lymph edema, facial anomalies, and mental retardation.",
                    "chunk": 2
               },
               {
                    "pmid": "29527032",
                    "text": "We report a case of this syndrome with typical clinical findings.",
                    "chunk": 2
               },
               {
                    "pmid": "29545249",
                    "text": "Medical records were reviewed to determine the symptoms of PHACE syndrome.",
                    "chunk": 5
               },
               {
                    "pmid": "29528714",
                    "text": "Symptoms such as feeding intolerance, emesis, or failure to pass meconium may prompt a radiologic evaluation.",
                    "chunk": 2
               },
               {
                    "pmid": "29525570",
                    "text": "The clinical presentation of MERS-CoV infection ranges from asymptomatic to very severe disease, and the classical presentation includes fever, cough chills, sore throat, myalgia, and arthralgia.",
                    "chunk": 2
               },
               {
                    "pmid": "29529530",
                    "text": "MS can have various clinical manifestations, one of which is olfactory dysfunction.",
                    "chunk": 2
               },
               {
                    "pmid": "29557732",
                    "text": "This work summarizes the main clinical features of these syndromes, their associated comorbidities and the clues for the differential diagnosis with other lipodystrophic disorders.",
                    "chunk": 6
               },
               {
                    "pmid": "29535059",
                    "text": "Diarrhea was the predominant symptoms in all patients MC, irrespective of comorbidities.",
                    "chunk": 10
               },
               {
                    "pmid": "29535429",
                    "text": "We review the clinical features of these syndromes, discuss the underlying biology, and interpret the genetic findings in some of the affected family members.",
                    "chunk": 8
               }
          ],
          "exact_answer": [
               [
                    "amegakaryocytic thrombocytopenia"
               ],
               [
                    "lymphangiectasia"
               ],
               [
                    "lymph edema"
               ],
               [
                    "facial anomalies"
               ],
               [
                    "mental retardation"
               ],
               [
                    "feeding intolerance"
               ],
               [
                    "emesis"
               ],
               [
                    "failure to pass meconium"
               ],
               [
                    "fever"
               ],
               [
                    "cough"
               ],
               [
                    "chills"
               ],
               [
                    "sore throat"
               ],
               [
                    "myalgia"
               ],
               [
                    "arthralgia"
               ],
               [
                    "olfactory dysfunction"
               ],
               [
                    "diarrhea"
               ]
          ],
          "ideal_answer": "MECOM-associated syndrome is a heterogeneous inherited bone marrow failure syndrome with amegakaryocytic thrombocytopenia. Clinical symptoms of various syndromes can include lymphangiectasia, lymph edema, facial anomalies, mental retardation, feeding intolerance, emesis, failure to pass meconium, fever, cough, chills, sore throat, myalgia, arthralgia, olfactory dysfunction and diarrhea."
     },
     {
          "id": "5c928303ecadf2e73f000014",
          "body": "What is the difference between the nuclease Cas13a and C2c2",
          "type": "summary",
          "documents": [
               "29523384",
               "29595998",
               "29575326",
               "29551514",
               "29531313",
               "29584876",
               "29605859",
               "29562705"
          ],
          "snippets": [
               {
                    "pmid": "29575326",
                    "text": "Recently, with the discovery of the nuclease Cas13a (previously called C2c2), molecular biologists have obtained a system that enables sequence-specific cleavage of single-stranded RNA molecules.",
                    "chunk": 4
               },
               {
                    "pmid": "29575326",
                    "text": "Cas9 and Cas12 (previously called Cpf1) are widely used as DNA nucleases for inducing site-specific DNA breaks for different kinds of genome engineering applications, and in their mutated forms as DNA-binding proteins to modify gene expression.",
                    "chunk": 2
               },
               {
                    "pmid": "29562705",
                    "text": "Unlike zinc-finger nucleases (ZFNs) and transcription activator-like effector nucleases (TALENs), CRISPR/Cas9 takes advantage of an RNA-guided DNA endonuclease enzyme, Cas9, which is able to generate double-strand breaks (DSBs) at specific genomic locations.",
                    "chunk": 3
               },
               {
                    "pmid": "29531313",
                    "text": "CRISPR-Cas12a has both cis- and trans-cleavage activities on single-stranded DNA.",
                    "chunk": 0
               },
               {
                    "pmid": "29575326",
                    "text": "The latest experiments with this and also the alternative Cas13b system demonstrate that these proteins can be used in a similar manner in eukaryotes for RNA manipulation as Cas9 and Cas12 for DNA manipulations.",
                    "chunk": 5
               },
               {
                    "pmid": "29551514",
                    "text": "Cas13d Is a Compact RNA-Targeting Type VI CRISPR Effector Positively Modulated by a WYL-Domain-Containing Accessory Protein.",
                    "chunk": 0
               },
               {
                    "pmid": "29523384",
                    "text": "Among the three nucleases, CRISPR-Cas9 is the best for breeding, crop improvement, and the functional analysis of genes of interest, because of its simplicity and high efficiency.",
                    "chunk": 3
               },
               {
                    "pmid": "29584876",
                    "text": "As the underlying mechanism, we found that the HNH domain, which is preserved in the D10A Cas9 nickase, has higher activity than the RuvC domain in mammalian cells.",
                    "chunk": 5
               },
               {
                    "pmid": "29595998",
                    "text": "We compare the mechanisms of Argonaute and CRISPR with a well-studied target search system, RecA.",
                    "chunk": 8
               },
               {
                    "pmid": "29605859",
                    "text": "The advent of CRISPR/Cas systems has provided simple, efficient, and targeted genetic manipulation in eukaryotes, which can be applied to studying genome structure and function.The basic CRISPR toolkit comprises an endonuclease, Cas9, and a short DNA-targeting sequence, made up of a single guide RNA (sgRNA).",
                    "chunk": 2
               }
          ],
          "exact_answer": null,
          "ideal_answer": "Cas13a, previously named C2c2, is a nuclease that cleaves single-stranded RNA molecules in a sequence-specific manner. Cas13a is an RNA-guided system while Cas9 and Cas12 are DNA nucleases that induce site-specific DNA breaks. "
     },
     {
          "id": "5c6ad2997c78d69471000020",
          "body": "Which Python tool has been developed for network-based stratification of tumor mutations?",
          "type": "factoid",
          "documents": [
               "29594039",
               "29530001",
               "29608663",
               "29611034",
               "29580235",
               "29552334",
               "29535832"
          ],
          "snippets": [
               {
                    "pmid": "29608663",
                    "text": "pyNBS: a Python implementation for network-based stratification of tumor mutations.",
                    "chunk": 0
               },
               {
                    "pmid": "29608663",
                    "text": "Summary: We present pyNBS: a modularized Python 2.7 implementation of the network-based stratification (NBS) algorithm for stratifying tumor somatic mutation profiles into molecularly and clinically relevant subtypes.",
                    "chunk": 1
               },
               {
                    "pmid": "29611034",
                    "text": "We describe some of the tools and database that are available for the annotation of somatic variants and the identification of cancer driver genes.",
                    "chunk": 5
               },
               {
                    "pmid": "29608663",
                    "text": "In addition to release of the software, we benchmark its key parameters and provide a compact cancer reference network that increases the significance of tumor stratification using the NBS algorithm.",
                    "chunk": 2
               },
               {
                    "pmid": "29530001",
                    "text": "These could be used as a powerful and novel method of tumor classification, offering a potential clinical tool for prognosis and therapeutic stratification.",
                    "chunk": 10
               },
               {
                    "pmid": "29594039",
                    "text": "Somatic SNVs from each tumor sample were used to reconstruct phylogenies of samples from each patient.",
                    "chunk": 4
               },
               {
                    "pmid": "29552334",
                    "text": "Detection of somatic mutations holds great potential in cancer treatment and has been a very active research field in the past few years, especially since the breakthrough of the next-generation sequencing technology.",
                    "chunk": 1
               },
               {
                    "pmid": "29535832",
                    "text": "Here, we aimed to evaluate the mutational profiles and phylogeny of sarcomatoid carcinomas using next generation sequencing and  METHODS: Four patients who underwent surgery for sarcomatoid cancer were enrolled.",
                    "chunk": 2
               },
               {
                    "pmid": "29552334",
                    "text": "A review of somatic single nucleotide variant calling algorithms for next-generation sequencing data.",
                    "chunk": 0
               },
               {
                    "pmid": "29580235",
                    "text": "METHODS: We tested the performance of four prediction tools (Align-GVGD, SIFT, PolyPhen-2, MutationTaster2) using a set of 236 BRCA1/2 missense variants that had previously been classified by expert committees.",
                    "chunk": 4
               }
          ],
          "exact_answer": "PyNBS",
          "ideal_answer": "PyNBS, a modularized Python 2.7 implementation of the network-based stratification (NBS) algorithm, has been developed for network-based stratification of tumor mutations."
     },
     {
          "id": "5c6ad3be7c78d69471000021",
          "body": "Are there tools for visualizing and processing long-read sequencing data?",
          "type": "yesno",
          "documents": [
               "29608746",
               "29547981",
               "29590101",
               "29529268",
               "29573184",
               "29536434",
               "29543431",
               "29554948",
               "29599501"
          ],
          "snippets": [
               {
                    "pmid": "29599501",
                    "text": "Several new genomics technologies have become available that offer long-read sequencing or long-range mapping with higher throughput and higher resolution analysis than ever before.",
                    "chunk": 1
               },
               {
                    "pmid": "29547981",
                    "text": "NanoPack: visualizing and processing long-read sequencing data.",
                    "chunk": 0
               },
               {
                    "pmid": "29554948",
                    "text": "A variety of bioinformatic tools were used to analyse the data generated, and the effects of sequencing depth on these analyses were tested by randomly subsampling reads.",
                    "chunk": 5
               },
               {
                    "pmid": "29547981",
                    "text": "Summary: Here we describe NanoPack, a set of tools developed for visualization and processing of long-read sequencing data from Oxford Nanopore Technologies and Pacific Biosciences.",
                    "chunk": 1
               },
               {
                    "pmid": "29590101",
                    "text": "As input, this tool requires a read alignment file (BAM format), lists of non-overlapping genome coordinates for introduction of gains and losses (bed file), and an optional file defining known haplotypes (vcf format).",
                    "chunk": 5
               },
               {
                    "pmid": "29536434",
                    "text": "This chapter is an overview of DNA sequencing technology and its data analysis methods, providing information about DNA sequencing, several different methods, and tools applied in data analysis.",
                    "chunk": 3
               },
               {
                    "pmid": "29543431",
                    "text": "The next generation sequencing (NGS) technologies have been rapidly evolved and applied to various research fields, but they often suffer from losing long-range information due to short library size and read length.",
                    "chunk": 1
               },
               {
                    "pmid": "29608746",
                    "text": "A highly discriminative and time-efficient bioinformatics tool is needed to transform large amounts of sequencing data into usable biological information.",
                    "chunk": 2
               },
               {
                    "pmid": "29573184",
                    "text": "High-throughput sequencing is a powerful tool, but suffers biases and errors that must be accounted for to prevent false biological conclusions.",
                    "chunk": 1
               },
               {
                    "pmid": "29529268",
                    "text": "Effective integrative and interactive visual and statistical tools to analyze many metagenomic samples can greatly increase the value of these data for researchers.",
                    "chunk": 3
               }
          ],
          "exact_answer": "Yes",
          "ideal_answer": "NanoPack is a tool developed for visualizing and processing long-read sequencing data."
     },
     {
          "id": "5c890c3375a4a5d21900000e",
          "body": "Can oleuropein aglycone interfere with amyloid aggregation?",
          "type": "yesno",
          "documents": [
               "29571746",
               "29577365",
               "29580826",
               "29600961",
               "29593399",
               "29603125"
          ],
          "snippets": [
               {
                    "pmid": "29571746",
                    "text": "It has been reported that the aglycone form of Oleuropein (OleA) interferes in vitro and in vivo with amyloid aggregation of a number of proteins/peptides involved in amyloid, particularly neurodegenerative, diseases avoiding the growth of toxic oligomers and displaying protection against cognitive deterioration.",
                    "chunk": 4
               },
               {
                    "pmid": "29571746",
                    "text": "Oleuropein aglycone: A polyphenol with different targets against amyloid toxicity.",
                    "chunk": 0
               },
               {
                    "pmid": "29571746",
                    "text": "GENERAL SIGNIFICANCE: The data provided in the present article focus on OleA protection, featuring this polyphenol as a promising plant molecule useful against amyloid diseases.",
                    "chunk": 8
               },
               {
                    "pmid": "29593399",
                    "text": "Therefore, the binding of fullerene and fullerenol could inhibit amyloid aggregation.",
                    "chunk": 7
               },
               {
                    "pmid": "29571746",
                    "text": "CONCLUSIONS: This study reveals that OleA remodels not only D76N b2m aggregates but also the cell membrane interfering with the misfolded proteins-cell membrane association, in most cases an early event triggering amyloid-mediated cytotoxicity.",
                    "chunk": 7
               },
               {
                    "pmid": "29603125",
                    "text": "The natural product (-)-epigallocatechin-3-gallate (EGCG) can redirect this process away from amyloid fibrils and towards non-toxic oligomers.",
                    "chunk": 2
               },
               {
                    "pmid": "29577365",
                    "text": "We investigated if oleuropein, a component of extra virgin olive oil, exerts a similar effect on postprandial glycaemia and the underlying mechanism.",
                    "chunk": 2
               },
               {
                    "pmid": "29580826",
                    "text": "Since aggregates such as lipofuscin and β-amyloid are known to impair proteostasis, it is likely to assume similar effects for human amylin.",
                    "chunk": 7
               },
               {
                    "pmid": "29600961",
                    "text": "Targeting of nonlipidated, aggregated apoE with antibodies inhibits amyloid accumulation.",
                    "chunk": 0
               },
               {
                    "pmid": "29577365",
                    "text": "Oleuropein, a component of extra virgin olive oil, lowers postprandial glycaemia in healthy subjects.",
                    "chunk": 0
               }
          ],
          "exact_answer": "Yes",
          "ideal_answer": "Oleuropein aglycone interferes in vitro and in vivo with amyloid aggregation of proteins/peptides involved in amyloid diseases."
     },
     {
          "id": "5c93e8bdecadf2e73f00001c",
          "body": "Which syndrome is associated to SAMHD1 gene mutations?",
          "type": "factoid",
          "documents": [
               "29549529",
               "29594836",
               "29535429",
               "29604126",
               "29554304"
          ],
          "snippets": [
               {
                    "pmid": "29594836",
                    "text": "This disease is caused by mutations in seven different genes encoding proteins implicated in the metabolism of nucleic acids, including SAMHD1.",
                    "chunk": 2
               },
               {
                    "pmid": "29535429",
                    "text": "Germline mutations in the SAMD9 and SAMD9L genes, located in tandem on chromosome 7, are associated with a clinical spectrum of disorders including the MIRAGE syndrome, ataxia-pancytopenia syndrome and myelodysplasia and leukemia syndrome with monosomy 7 syndrome.",
                    "chunk": 1
               },
               {
                    "pmid": "29604126",
                    "text": "Consistent with previous data, SAM syndrome was found in all 3 patients to result from homozygous mutations in DSG1 predicted to result in premature termination of translation.",
                    "chunk": 5
               },
               {
                    "pmid": "29604126",
                    "text": "SAM syndrome is characterized by extensive phenotypic heterogeneity.",
                    "chunk": 0
               },
               {
                    "pmid": "29604126",
                    "text": "We present 3 new cases of SAM syndrome in 2 families and review the cases published so far.",
                    "chunk": 3
               },
               {
                    "pmid": "29535429",
                    "text": "SAMD9 mutations appear to associate with a more severe disease phenotype, including intrauterine growth restriction, developmental delay and hypoplasia of adrenal glands, testes, ovaries or thymus, and most reported patients died in infancy or early childhood due to infections, anemia and/or hemorrhages.",
                    "chunk": 6
               },
               {
                    "pmid": "29604126",
                    "text": "The present data emphasize the fact that SAM syndrome is characterized by extensive phenotypic heterogeneity, suggesting the existence of potent modifier traits.",
                    "chunk": 7
               },
               {
                    "pmid": "29535429",
                    "text": "SAMD9L mutations have been reported in a few families with balance problems and nystagmus due to cerebellar atrophy, and may lead to similar hematological disease as seen in SAMD9 mutation carriers, from early childhood to adult years.",
                    "chunk": 7
               },
               {
                    "pmid": "29554304",
                    "text": "Kleefstra syndrome, a disease with intellectual disability, autism spectrum disorders and other developmental defects is caused in humans by haploinsufficiency of EHMT1.",
                    "chunk": 1
               },
               {
                    "pmid": "29549529",
                    "text": "PURPOSE: The myelodysplastic syndromes (MDS) are a group of hematologic disorders characterized by the presence of somatically mutated hematopoietic stem cells (HSCs) that increase the risk of progression to secondary acute myeloid leukemia (sAML).",
                    "chunk": 1
               }
          ],
          "exact_answer": "Disease implicated in the metabolism of nucleic acids",
          "ideal_answer": "Mutations in the SAMHD1 gene are associated with an unspecified disease implicated in the metabolism of nucleic acids."
     },
     {
          "id": "5e2dadcffbd6abf43b000011",
          "body": "What are the most common side effects of amantadine ER?",
          "type": "list",
          "documents": [
               "29573400",
               "29542337",
               "29564954",
               "29532516",
               "29575039",
               "29534693",
               "29561204",
               "29536911"
          ],
          "snippets": [
               {
                    "pmid": "29564954",
                    "text": "Amantadine ER reduces the severity and duration of dyskinesia during the day, reduces OFF time and increases ON time without troublesome dyskinesia.",
                    "chunk": 6
               },
               {
                    "pmid": "29564954",
                    "text": "This review discusses the safety and efficacy of amantadine ER in dyskinesia in PD patients.",
                    "chunk": 8
               },
               {
                    "pmid": "29573400",
                    "text": "The most frequent side effects were psychiatric disorders, instability, dizziness and irritability, and mostly resolved with dose reduction.",
                    "chunk": 11
               },
               {
                    "pmid": "29534693",
                    "text": "It is typically a side effect of some medications.",
                    "chunk": 2
               },
               {
                    "pmid": "29564954",
                    "text": "The most common side effects are hallucination, dizziness, orthostatic hypotension and pedal edema.",
                    "chunk": 7
               },
               {
                    "pmid": "29542337",
                    "text": "EXPERT OPINION: AMs are generally considered to have good CV safety profile but, however, they may cause undesirable adverse events, such as dry mouth, constipation.",
                    "chunk": 6
               },
               {
                    "pmid": "29532516",
                    "text": "OBJECTIVE: Antihistamines often have sedative side effects.",
                    "chunk": 1
               },
               {
                    "pmid": "29575039",
                    "text": "The most common side effect associated with treatment was gastrointestinal intolerance and headache.",
                    "chunk": 9
               },
               {
                    "pmid": "29536911",
                    "text": "Common side effects of IM injection, including transient injection site pain and inflammation, are common and well described.",
                    "chunk": 2
               },
               {
                    "pmid": "29561204",
                    "text": "The most common adverse events were nausea, dizziness and blurred vision.",
                    "chunk": 10
               }
          ],
          "exact_answer": [
               [
                    "psychiatric disorders"
               ],
               [
                    "instability"
               ],
               [
                    "dizziness"
               ],
               [
                    "irritability"
               ],
               [
                    "hallucination"
               ],
               [
                    "orthostatic hypotension"
               ],
               [
                    "pedal edema"
               ],
               [
                    "dry mouth"
               ],
               [
                    "constipation"
               ],
               [
                    "nausea"
               ],
               [
                    "blurred vision"
               ]
          ],
          "ideal_answer": "The most frequent side effects of amantadine ER include psychiatric disorders, instability, dizziness, and irritability, which often resolve with dose reduction. Additional common side effects associated with amantadine ER are hallucinations, orthostatic hypotension, and pedal edema. Other reported adverse events include dry mouth, constipation, nausea, and blurred vision."
     },
     {
          "id": "5e2db15cfbd6abf43b000014",
          "body": "Has amantadine ER been approved by the FDA?",
          "type": "yesno",
          "documents": [
               "29523624",
               "29564954",
               "29570959",
               "29532440",
               "29536134",
               "29557246"
          ],
          "snippets": [
               {
                    "pmid": "29564954",
                    "text": "This review discusses the safety and efficacy of amantadine ER in dyskinesia in PD patients.",
                    "chunk": 8
               },
               {
                    "pmid": "29564954",
                    "text": "Extended-release amantadine (amantadine ER) is the first approved medication for the treatment of dyskinesia.",
                    "chunk": 4
               },
               {
                    "pmid": "29532440",
                    "text": "ADS-5102 (amantadine) extended-release (ER) capsules (GOCOVRI OBJECTIVE: In this study, we present pooled results from two randomized, double-blind, placebo-controlled, phase III ADS-5102 trials.",
                    "chunk": 2
               },
               {
                    "pmid": "29570959",
                    "text": "Galantamine and memantine are approved by the US Food and Drug Administration (FDA) for the treatment of Alzheimer's disease (AD).",
                    "chunk": 5
               },
               {
                    "pmid": "29564954",
                    "text": "Amantadine ER reduces the severity and duration of dyskinesia during the day, reduces OFF time and increases ON time without troublesome dyskinesia.",
                    "chunk": 6
               },
               {
                    "pmid": "29523624",
                    "text": "U.S. Food and Drug Administration Approval: Neratinib for the Extended Adjuvant Treatment of Early-Stage HER2-Positive Breast Cancer.",
                    "chunk": 0
               },
               {
                    "pmid": "29564954",
                    "text": "The role of extended-release amantadine for the treatment of dyskinesia in Parkinson's disease patients.",
                    "chunk": 0
               },
               {
                    "pmid": "29536134",
                    "text": "PURPOSE: The labeling information, authorized by the US Food and Drug Administration (FDA) and the European Medicines Agency (EMA), is expected to guide the method of drug administration with reference to meal intake, aiming at ensuring favorable safety profile and achieving optimal drug exposure.",
                    "chunk": 1
               },
               {
                    "pmid": "29532440",
                    "text": "Pooled Analyses of Phase III Studies of ADS-5102 (Amantadine) Extended-Release Capsules for Dyskinesia in Parkinson's Disease.",
                    "chunk": 0
               },
               {
                    "pmid": "29557246",
                    "text": "Expert Commentary: Dupilumab was approved by the FDA in April 2017 for the treatment of adult patients with moderate-to-severe atopic dermatitis whose disease is not adequately controlled with topical prescription therapies or when those therapies are not advisable.",
                    "chunk": 11
               }
          ],
          "exact_answer": "Yes",
          "ideal_answer": "Amantadine ER is the first approved medication for the treatment of dyskinesia."
     },
     {
          "id": "5e2dad57fbd6abf43b000010",
          "body": "Is amantadine ER the first approved treatment for akinesia?",
          "type": "yesno",
          "documents": [
               "29525646",
               "29564954",
               "29570866",
               "29608501",
               "29532440",
               "29568276"
          ],
          "snippets": [
               {
                    "pmid": "29564954",
                    "text": "Extended-release amantadine (amantadine ER) is the first approved medication for the treatment of dyskinesia.",
                    "chunk": 4
               },
               {
                    "pmid": "29564954",
                    "text": "This review discusses the safety and efficacy of amantadine ER in dyskinesia in PD patients.",
                    "chunk": 8
               },
               {
                    "pmid": "29564954",
                    "text": "The role of extended-release amantadine for the treatment of dyskinesia in Parkinson's disease patients.",
                    "chunk": 0
               },
               {
                    "pmid": "29532440",
                    "text": "Pooled Analyses of Phase III Studies of ADS-5102 (Amantadine) Extended-Release Capsules for Dyskinesia in Parkinson's Disease.",
                    "chunk": 0
               },
               {
                    "pmid": "29564954",
                    "text": "Amantadine ER reduces the severity and duration of dyskinesia during the day, reduces OFF time and increases ON time without troublesome dyskinesia.",
                    "chunk": 6
               },
               {
                    "pmid": "29564954",
                    "text": "Levodopa is the most efficacious treatment for Parkinson's disease (PD).",
                    "chunk": 1
               },
               {
                    "pmid": "29608501",
                    "text": "Beta-adrenergic receptor antagonists, or β-blockers, have been a cornerstone of treatment in patients with acute coronary syndromes (ACS) for more than 4 decades.",
                    "chunk": 1
               },
               {
                    "pmid": "29570866",
                    "text": "For treating motor fluctuations, most nonergot dopamine agonists, pergolide, levodopa ER, levodopa intestinal infusion, entacapone, opicapone, rasagiline, zonisamide, safinamide, and bilateral STN and GPi DBS are clinically useful.",
                    "chunk": 12
               },
               {
                    "pmid": "29525646",
                    "text": "One approach involves treating mutant RNA through antisense oligonucleotides; the first drug has received regulatory approval to treat specific mutations associated with Duchenne muscular dystrophy.",
                    "chunk": 2
               },
               {
                    "pmid": "29568276",
                    "text": "OBJECTIVES: Risperidone is the first new generation antipsychotic drug to become available as a long-acting injection (LAI).",
                    "chunk": 2
               }
          ],
          "exact_answer": "No",
          "ideal_answer": "Amantadine ER is the first approved treatment for dyskinesia, not akinesia."
     },
     {
          "id": "5e369c30b5b409ea53000001",
          "body": "Describe ChromoTrace",
          "type": "summary",
          "documents": [
               "29564815",
               "29564830",
               "29522506",
               "29557669",
               "29564814",
               "29564831"
          ],
          "snippets": [
               {
                    "pmid": "29522506",
                    "text": "ChromoTrace: Computational reconstruction of 3D chromosome configurations for super-resolution microscopy.",
                    "chunk": 0
               },
               {
                    "pmid": "29564814",
                    "text": "Furthermore, we will give an overview of recent insights into the mechanisms underlying chromothripsis.",
                    "chunk": 8
               },
               {
                    "pmid": "29564814",
                    "text": "In this chapter, we will outline the genomic characteristics of chromothripsis, and we present genomic methodologies that enable the detection of chromothripsis.",
                    "chunk": 7
               },
               {
                    "pmid": "29522506",
                    "text": "Our reconstruction method, ChromoTrace, uses suffix trees to assign a known linear ordering of in situ probes on the genome to an unknown set of 3D in-situ probe positions in the nucleus from super-resolved images using the known genomic probe spacing as a set of physical distance constraints between probes.",
                    "chunk": 8
               },
               {
                    "pmid": "29564814",
                    "text": "The Genomic Characteristics and Origin of Chromothripsis.",
                    "chunk": 0
               },
               {
                    "pmid": "29564815",
                    "text": "In this chapter, we use the term \"chromoanagenesis\" to indicate all catastrophic events including chromothripsis.",
                    "chunk": 5
               },
               {
                    "pmid": "29522506",
                    "text": "We find that ChromoTrace can assign the 3D positions of the majority of loci with high accuracy and reasonable sensitivity to specific genome sequences.",
                    "chunk": 9
               },
               {
                    "pmid": "29564830",
                    "text": "We also provide practical recommendations for effective chromothripsis detection.",
                    "chunk": 5
               },
               {
                    "pmid": "29557669",
                    "text": "Telemonitoring in Chronic Obstructive Pulmonary Disease (CHROMED).",
                    "chunk": 0
               },
               {
                    "pmid": "29564831",
                    "text": "At present, the molecular mechanisms involved in chromothripsis phenomenon are not fully understood.",
                    "chunk": 4
               }
          ],
          "exact_answer": null,
          "ideal_answer": "ChromoTrace is a computational method that reconstructs 3D chromosome configurations from super-resolution microscopy images. It uses suffix trees to assign a known linear ordering of in situ probes on the genome to an unknown set of 3D in-situ probe positions in the nucleus. The method utilizes known genomic probe spacing as physical distance constraints between probes, enabling the accurate assignment of 3D positions to specific genome sequences."
     },
     {
          "id": "5e51a7ec6d0a27794100003b",
          "body": "What is SpatialDE?",
          "type": "summary",
          "documents": [
               "29553579",
               "29520553",
               "29555340",
               "29545731",
               "29518565",
               "29522747",
               "29550452",
               "29530517"
          ],
          "snippets": [
               {
                    "pmid": "29553579",
                    "text": "Here we describe SpatialDE, a statistical test to identify genes with spatial patterns of expression variation from multiplexed imaging or spatial RNA-sequencing data.",
                    "chunk": 3
               },
               {
                    "pmid": "29553579",
                    "text": "SpatialDE: identification of spatially variable genes.",
                    "chunk": 0
               },
               {
                    "pmid": "29518565",
                    "text": "Spatial attention is the cognitive function that coordinates the selection of visual stimuli with appropriate behavioral responses.",
                    "chunk": 1
               },
               {
                    "pmid": "29522747",
                    "text": "Spatial organization is a hallmark of all living systems.",
                    "chunk": 1
               },
               {
                    "pmid": "29550452",
                    "text": "The motivation for researching this issue is that spatial structure is a source of new biological insights with management interest.",
                    "chunk": 4
               },
               {
                    "pmid": "29530517",
                    "text": "Spatial frequency is an elementary aspect of visual perception.",
                    "chunk": 3
               },
               {
                    "pmid": "29555340",
                    "text": "Spatial memory enables us to locate places and objects in space, to determine our position and manage spatial relationships in our environment.",
                    "chunk": 1
               },
               {
                    "pmid": "29553579",
                    "text": "SpatialDE also implements 'automatic expression histology', a spatial gene-clustering approach that enables expression-based tissue histology.",
                    "chunk": 4
               },
               {
                    "pmid": "29545731",
                    "text": "Spatial perspective taking is the ability to reason about spatial relations relative to another's viewpoint.",
                    "chunk": 1
               },
               {
                    "pmid": "29520553",
                    "text": "This spatial inequity is essentially related to land use and agricultural production system.",
                    "chunk": 8
               }
          ],
          "exact_answer": null,
          "ideal_answer": "SpatialDE is a statistical test designed to identify genes exhibiting spatial patterns of expression variation from multiplexed imaging or spatial RNA-sequencing data. It also implements 'automatic expression histology', a spatial gene-clustering approach that enables expression-based tissue histology."
     },
     {
          "id": "5e494b0e6d0a277941000007",
          "body": "List 3 PD-L1 inhibitors on the market as of 2018.",
          "type": "list",
          "documents": [
               "29556232",
               "29545941",
               "29525401",
               "29607153",
               "29552320",
               "29517083",
               "29549910",
               "29571563",
               "29574334",
               "29593889"
          ],
          "snippets": [
               {
                    "pmid": "29571563",
                    "text": "Nevertheless, new therapies have emerged recently, among which PD1 immune checkpoint inhibitors (ICI), such as nivolumab (OPDIVO",
                    "chunk": 2
               },
               {
                    "pmid": "29545941",
                    "text": "BACKGROUND: Programmed cell death 1 (PD-1) and programmed cell death-ligand 1(PD-L1) inhibitors have captured our attention as new therapeutic options for several tumor types.",
                    "chunk": 1
               },
               {
                    "pmid": "29593889",
                    "text": "The PD1 inhibitors such as pembrolizumab have now received FDA approval in the first-line setting for patients with positive PD-L1 expression tumor types; however, only a portion of patients have shown objective and sustainable responses.",
                    "chunk": 5
               },
               {
                    "pmid": "29525401",
                    "text": "A number of immune check-point inhibitors (ICIs) targeting both PD-1 and CTLA-4 pathways are under investigation within clinical trials, of which Nivolumab, Pembrolizumab and Atezolizumab have already been approved for lung cancer treatment by both FDA and EMA.",
                    "chunk": 3
               },
               {
                    "pmid": "29552320",
                    "text": "We conducted this study to identify which patients could benefit more from the treatment of programmed death-1 (PD-1)/programmed death-ligand1 (PD-L1) inhibitors.",
                    "chunk": 2
               },
               {
                    "pmid": "29517083",
                    "text": "Five antibodies targeting the programmed cell death protein 1--programmed cell death 1 ligand 1 (PD-1--PD-L1) pathway have been approved by the U.S. Food and Drug Administration (FDA) for the management of various malignancies: pembrolizumab, nivolumab, atezolizumab, durvalumab and avelumab.",
                    "chunk": 4
               },
               {
                    "pmid": "29574334",
                    "text": "Anti-PD-1 blockers have been recently approved by US and EU regulatory agencies in this setting.",
                    "chunk": 6
               },
               {
                    "pmid": "29549910",
                    "text": "OBJECTIVES: Programmed death-1 (PD-1) and programmed death-ligand 1 (PD-L1) inhibitors have been approved as a standard therapy for metastatic non-small cell lung cancer (NSCLC).",
                    "chunk": 1
               },
               {
                    "pmid": "29556232",
                    "text": "Improving the efficacy of PD-1 and PD-L1 blockade therapy is clearly needed.",
                    "chunk": 3
               },
               {
                    "pmid": "29607153",
                    "text": "BACKGROUND: Programmed cell death-1 (PD-1) and programmed cell death ligand-1 (PD-L1) have been identified as novel targets for immunotherapy, with PD-L1 as a potential predictive biomarker.",
                    "chunk": 1
               }
          ],
          "exact_answer": [
               [
                    "nivolumab"
               ],
               [
                    "pembrolizumab"
               ],
               [
                    "atezolizumab"
               ]
          ],
          "ideal_answer": "As of 2018, several PD-1 and PD-L1 inhibitors were approved by the FDA and EMA for lung cancer treatment and other malignancies. These include nivolumab, pembrolizumab, and atezolizumab. Additionally, durvalumab and avelumab were also approved by the FDA for managing various malignancies by targeting the PD-1/PD-L1 pathway."
     },
     {
          "id": "602c2ade1cb411341a000124",
          "body": "Are TAMs good anticancer therapeutic targets?",
          "type": "yesno",
          "documents": [
               "29556295",
               "29594035",
               "29522753",
               "29528567",
               "29602128",
               "29580896",
               "29544641",
               "29565447",
               "29541204"
          ],
          "snippets": [
               {
                    "pmid": "29594035",
                    "text": "Integrating therapeutic strategies to target TAMs to complement conventional therapies has yielded promising results in preclinical trials and warrants further investigation to determine its translational benefit in human cancer patients.",
                    "chunk": 6
               },
               {
                    "pmid": "29580896",
                    "text": "As such, it has represented a promising therapeutic target for cancer.",
                    "chunk": 2
               },
               {
                    "pmid": "29556295",
                    "text": "and has been identified as a therapeutic target for various types of cancer.",
                    "chunk": 2
               },
               {
                    "pmid": "29522753",
                    "text": "ATM is an attractive target for cancer treatment.",
                    "chunk": 3
               },
               {
                    "pmid": "29602128",
                    "text": "This turns it into an interesting target in the treatment of different malignancies.",
                    "chunk": 4
               },
               {
                    "pmid": "29594035",
                    "text": "In most solid cancers, increased infiltration with tumor-associated macrophages (TAMs) has long been associated with poor patient prognosis, highlighting their value as potential diagnostic and prognostic biomarkers in cancer.",
                    "chunk": 4
               },
               {
                    "pmid": "29541204",
                    "text": "Accumulating studies have indicated that PKM2 is a potential target for cancer therapy.",
                    "chunk": 3
               },
               {
                    "pmid": "29565447",
                    "text": "Therefore, CAFs may be a new therapeutic target for the treatment of ovarian cancer.",
                    "chunk": 23
               },
               {
                    "pmid": "29544641",
                    "text": "hTS is a target for anticancer agents, some of which are clinical drugs.",
                    "chunk": 4
               },
               {
                    "pmid": "29528567",
                    "text": "TRAF1 may be an important therapeutic target for NSCLC.",
                    "chunk": 10
               }
          ],
          "exact_answer": "Yes",
          "ideal_answer": "Tumor-associated macrophages (TAMs) have been identified as promising therapeutic targets for cancer, with preclinical trials showing promising results."
     }
]